1. Home
  2. KNSA vs EVTC Comparison

KNSA vs EVTC Comparison

Compare KNSA & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • EVTC
  • Stock Information
  • Founded
  • KNSA 2015
  • EVTC 1988
  • Country
  • KNSA United Kingdom
  • EVTC United States
  • Employees
  • KNSA N/A
  • EVTC N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • EVTC EDP Services
  • Sector
  • KNSA Health Care
  • EVTC Technology
  • Exchange
  • KNSA Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • KNSA 1.9B
  • EVTC 2.1B
  • IPO Year
  • KNSA 2018
  • EVTC 2013
  • Fundamental
  • Price
  • KNSA $33.28
  • EVTC $37.12
  • Analyst Decision
  • KNSA Strong Buy
  • EVTC Hold
  • Analyst Count
  • KNSA 6
  • EVTC 5
  • Target Price
  • KNSA $40.83
  • EVTC $39.00
  • AVG Volume (30 Days)
  • KNSA 711.9K
  • EVTC 350.1K
  • Earning Date
  • KNSA 07-29-2025
  • EVTC 07-30-2025
  • Dividend Yield
  • KNSA N/A
  • EVTC 0.54%
  • EPS Growth
  • KNSA N/A
  • EVTC 102.95
  • EPS
  • KNSA 0.07
  • EVTC 2.13
  • Revenue
  • KNSA $529,332,000.00
  • EVTC $886,589,000.00
  • Revenue This Year
  • KNSA $37.21
  • EVTC $7.87
  • Revenue Next Year
  • KNSA $6.10
  • EVTC $5.05
  • P/E Ratio
  • KNSA $504.35
  • EVTC $17.44
  • Revenue Growth
  • KNSA 56.18
  • EVTC 12.93
  • 52 Week Low
  • KNSA $17.82
  • EVTC $31.11
  • 52 Week High
  • KNSA $33.98
  • EVTC $38.56
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 65.73
  • EVTC 61.58
  • Support Level
  • KNSA $31.78
  • EVTC $34.19
  • Resistance Level
  • KNSA $33.66
  • EVTC $37.71
  • Average True Range (ATR)
  • KNSA 1.26
  • EVTC 0.74
  • MACD
  • KNSA 0.24
  • EVTC 0.42
  • Stochastic Oscillator
  • KNSA 90.63
  • EVTC 87.12

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

Share on Social Networks: